High Grade

Infectious Disease·MeSH: Adenoviridae Infections

17 drugs in development·14 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
Cabozantinib S-malate	Valneva SE (VALN)
rina-s	GENMAB A/S (GNMSF)

Phase 2(9)

Drug	Company
AZD6738	Merus N.V. (MRUS)
Cabozantinib S-malate	Assertio Holdings, Inc. (ASRT)
Entrectinib	Structure Therapeutics Inc. (GPCR)
Entrectinib	Filana Therapeutics Inc. (FLNA)
Etoposide	Structure Therapeutics Inc. (GPCR)
Pegfilgrastim	Filana Therapeutics Inc. (FLNA)
Pegfilgrastim	ADMA BIOLOGICS, INC. (ADMA)
Vinblastine Sulfate	ENANTA PHARMACEUTICALS INC (ENTA)
Vinblastine Sulfate	Structure Therapeutics Inc. (GPCR)

Phase 1(4)

Drug	Company
Birinapant	IGM Biosciences, Inc. (IGMS)
KT-253	Kymera Therapeutics, Inc. (KYMR)
Peposertib	Accustem Sciences Inc. (ACUT)
PTC596	PTC THERAPEUTICS, INC. (PTCT)

Phase 1/Phase 2(1)

Drug	Company
rina-s	Genmab A/S (GMAB)

Phase 4(1)

Drug	Company
olutasidenib + tmz	RIGEL PHARMACEUTICALS INC (RIGL)

BioSniper tracks 17 drugs in development for High Grade across 14 companies.

There are 1 clinical trial targeting High Grade tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.